Used as an intermediate in Suzuki-Miyaura cross-coupling reactions for the synthesis of complex organic molecules, particularly in pharmaceutical development. Its boron-containing group enables efficient carbon-carbon bond formation under mild conditions. Commonly employed in the preparation of bioactive compounds, including drug candidates targeting central nervous system disorders and oncology therapeutics. The protecting group enhances stability and solubility during multi-step syntheses, allowing selective reactivity. Also utilized in medicinal chemistry for constructing pyrrolidine-based scaffolds found in protease inhibitors and receptor modulators.